Cytidine-5'-diphosphocholine sodium salt hydrate acts as a neuroprotective agent in situations of hypoxia and ischemia. It is used as biosynthetic intermediate of membrane phospholipids. It is a cerebral vasodilator and inhibits PLA2 activation.
W.M.Clark; S.J.Warach; L.C.Pettigrew; R.E.Gammans; L.A.Sabounjian. A randomized dose-response trial of citicoline in acute ischemic stroke patients. Citicoline Stroke Study Group. Neurology. 1997, 49,(3), 671-678.
S.Warach, MD, PhD; L.Creed Pettigrew, MD; J.F.Dashe, MD, PhD; P.Pullicino MD; David M.Lefkowitz, MD; L.Sabounjian, RN; K.Harnett, MS; U.Schwiderski, PhD; R.Gammans, PhD. Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging. Annals of Neurology. 2000, 48,(5), 713-722.